comprehensive -WSS

comprehensive

author：explore 2025-09-29 21:25:59 - browse：48421

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Use wet bulb globe temperature, not heat index, to protect workers

focus

entertainment

WSS

CDC wastewater surveillance dashboard to track bird flu hotspots

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Eye stem cell transplant could help restore vision in injured people

H5N1 bird flu: what we're starting to learn about infection in cows

Study: Adult vaccinations pay for themselves in societal benefits

An interview with Robert F. Kennedy Jr. on vaccines

focus

comprehensive

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Eye stem cell transplant could help restore vision in injured people

New air purifier tech could be key to improving indoor air quality

What nurses really want: sufficient staffing for patient care

Affirmative action in medical school literally saved lives

New details revealed about Purdue's marketing of OxyContin

Duchenne breakthrough therapy leaves behind pioneering families

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

As demand for Covid shots wanes, Moderna seeks its next success

Listen: Racing for gene therapy & a pioneering approval

explore

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Hilary expected to bring catastrophic, life

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Software glitch causes Tandem insulin pump to shutdown, FDA warns

CDC wastewater surveillance dashboard to track bird flu hotspots

Patient advocates sound warning on FDA proposal on salt intake

explore

focus

entertainment

knowledge